CWM
SNDX icon

CIBC World Markets’s Syndax Pharmaceuticals SNDX Stock Holding History

CIBC World Markets’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$98.3K Sell
10,499
-7,734
-42% -$85.1K ﹤0.01% 1403
2025
Q1 		$224K Buy
+18,233
New +$257K ﹤0.01% 1409

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CIBC World Markets's SNDX Position: Q2 2025 in Review

CIBC World Markets reduced its Syndax Pharmaceuticals (SNDX) stake by 42% in Q2 2025, selling an estimated $85.1K and leaving 10,499 shares worth $98.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1403.

CIBC World Markets first reported a position in SNDX in Q1 2025 and has held it in 2 quarters since. The position peaked at $224K in Q1 2025. 216 funds tracked by Wall St. Rank hold SNDX as of Q2 2025.

  • CIBC World Markets held 10,499 shares of Syndax Pharmaceuticals worth $98.3K as of Q2 2025.
  • CIBC World Markets sold 7,734 Syndax Pharmaceuticals shares in Q2 2025, an estimated $85.1K.
  • Syndax Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1403 holding.
  • CIBC World Markets first reported a position in Syndax Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • CIBC World Markets's Syndax Pharmaceuticals position peaked at $224K in Q1 2025.
  • 216 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.